AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Izumoto, S Ohnishi, T Kanemura, H Arita, N Maruno, M Moriuchi, S Suzuki, T Yoshimine, T
Citation: S. Izumoto et al., PTEN mutations in malignant gliomas and their relation with meningeal gliomatosis, J NEURO-ONC, 53(1), 2001, pp. 21-26

Authors: Niranjan, A Moriuchi, S Lunsford, LD Kondziolka, D Flickinger, JC Fellows, W Rajendiran, S Tamura, M Cohen, JB Glorioso, JC
Citation: A. Niranjan et al., Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration, MOL THER, 2(2), 2000, pp. 114-120

Authors: Marconi, P Tamura, M Moriuchi, S Krisky, DM Niranjan, A Goins, WF Cohen, JB Glorioso, JC
Citation: P. Marconi et al., Connexin 43-enhanced suicide gene therapy using herpesviral vectors, MOL THER, 1(1), 2000, pp. 71-81

Authors: Mito, T Maekawa, R Iwamoto, A Imagawa, S Takahata, K Yamada, S Yanagi, N Nishimura, A Tamura, H Chikaraishi, H Hamaguchi, S Baba, T Moriuchi, S Oba, K Sekiguchi, H Otake, F Satow, T Nakamura, Y Satoh, S Motojima, O
Citation: T. Mito et al., Performance of the LHD cryogenic system during cooling and excitation tests, IEEE APPL S, 10(1), 2000, pp. 1507-1510

Authors: Moriuchi, S Krisky, DM Marconi, PC Tamura, M Shimizu, K Yoshimine, T Cohen, JB Glorioso, JC
Citation: S. Moriuchi et al., HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma, GENE THER, 7(17), 2000, pp. 1483-1490

Authors: Motojima, O Akaishi, K Chikaraishi, H Funaba, H Hamaguchi, S Imagawa, S Inagaki, S Inoue, I Iwamoto, A Kitagawa, S Komori, A Kubota, Y Maekawa, R Masuzaki, S Mito, T Miyazawa, J Morisaki, T Murai, K Muroga, T Nagasaka, T Nakamura, Y Nishimura, A Nishimura, K Noda, N Ohyabu, N Sagara, A Sakakibara, S Sakamoto, R Satoh, S Satow, T Shoji, M Suzuki, H Takahata, K Tamura, H Watanabe, KY Yamada, H Yamada, S Yamaguchi, S Yamazaki, K Yanagi, N Baba, T Hayashi, H Iima, M Inoue, T Kato, S Kato, T Kondo, T Moriuchi, S Ogawa, H Ohtake, I Ooba, K Sekiguchi, H Suzuki, N Takami, S Taniguchi, Y Tsuzuki, T Yamamoto, N Yasui, E Yonezu, H Fujiwara, M Iiyoshi, A
Citation: O. Motojima et al., Progress summary of LHD engineering design and construction, NUCL FUSION, 40(3Y), 2000, pp. 599-609

Authors: Tsutsumi, M Saito, K Moriuchi, S
Citation: M. Tsutsumi et al., Development of a detector for measuring effective dose (equivalent) for external photon exposures in natural environment, J NUC SCI T, 37(3), 2000, pp. 300-306

Authors: Miura, FK Cekic, O Moriuchi, S Aguiar, PH
Citation: Fk. Miura et al., Meningioma model, J NEUROSURG, 93(1), 2000, pp. 162-163

Authors: Mito, T Maekawa, R Yamada, S Nishimura, A Takahata, K Iwamoto, A Imagawa, S Watanabe, K Yanagi, N Tamura, H Baba, T Moriuchi, S Oba, K Sekiguchi, H Ohtake, I Satow, T Satoh, S Motojima, O
Citation: T. Mito et al., First cool-down performance of the LHD, IEEE APPL S, 9(2), 1999, pp. 640-643

Authors: Wolfe, D Goins, WF Yamada, M Moriuchi, S Krisky, DM Oligino, TJ Marconi, PC Fink, DJ Glorioso, JC
Citation: D. Wolfe et al., Engineering herpes simplex virus vectors for CNS applications, EXP NEUROL, 159(1), 1999, pp. 34-46

Authors: Ohtomo, T Kawata, H Sekimori, Y Shimizu, K Kishima, H Moriuchi, S Miyao, Y Akamatsu, KI Tsuchiya, M
Citation: T. Ohtomo et al., A humanized single-chain Fv fragment with high targeting potential againsthuman malignant gliomas, ANTICANC R, 18(6A), 1998, pp. 4311-4315

Authors: Moriuchi, S Oligino, T Krisky, D Marconi, P Fink, D Cohen, J Glorioso, JC
Citation: S. Moriuchi et al., Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase, CANCER RES, 58(24), 1998, pp. 5731-5737

Authors: Suzuki, T Piche, A Kasono, K Xiang, JL Gomez-Navarro, J Moriuchi, S Krisky, DM Oligino, T Glorioso, JC Curiel, TJ Curiel, DT
Citation: T. Suzuki et al., Efficient gene delivery into Epstein-Barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy, BIOC BIOP R, 252(3), 1998, pp. 686-690
Risultati: 1-13 |